GEHC vs SYK
GEHC: GE HealthCare provides a comprehensive suite of medical imaging, diagnostic pharmaceuticals, and AI-driven software to help clinicians deliver personalized, precise patient care. SYK: A diversified medical technology leader offering surgical equipment, orthopedic robotics, and minimally invasive neurovascular products that collectively serve over 150 million patients annually across 61 countries.
Side-by-side fundamentals
| Metric | GEHC | SYK | Edge |
|---|---|---|---|
| Price as of 2026-07-23 close | $61.99 | $318.97 | |
| Market cap as of 2026-07-24 | $28.2B | $120.8B | |
| P/E as of 2026-07-24 | 14.76 | 36.19 | GEHC lower |
| PEG as of 2026-07-24 | 2.18 | 3.29 | GEHC lower |
| Net margin as of 2026-07-24 | +9.1% | +13.2% | SYK higher |
| Gross margin as of 2026-07-24 | +39.1% | +64.2% | SYK higher |
| Operating margin as of 2026-07-24 | +12.6% | +19.7% | SYK higher |
| ROE as of 2026-07-24 | +18.8% | +15.1% | GEHC higher |
| ROA as of 2026-07-24 | +5.3% | +7.1% | SYK higher |
| Debt / equity as of 2026-07-24 | 0.95 | 0.64 | SYK lower |
| Revenue growth (YoY) as of 2026-07-24 | +6.0% | +8.8% | SYK higher |
| Revenue CAGR (3y) SEC XBRL | +4.0% | +10.8% | SYK higher |
| Dividend yield as of 2026-07-24 | +0.2% | +1.1% | SYK higher |
| Dividend streak (yrs) SEC XBRL | 3 | 5 | SYK higher |
| Beta as of 2026-07-24 | 0.85 | 0.77 | |
| 1-year return as of 2026-07-23 close | -19.7% | -20.4% | GEHC higher |
Fundamentals: Finnhub, as of 2026-07-24. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-23.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.